Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Liu Y-, Geyer JT. Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications. Pathobiology. 2024;91(1):30-44.

Boufaied N, Chetta P, Hallal T, Cacciatore S, Lalli D, Luthold C, et al. Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer. Cancer Res. 2024;84(11):1834-1855.

Gal J, Mosquera JM, Robinson BD, Schlegel PN. Incidental seminoma in nonobstructive azoospermia: a case report. F S Rep. 2024;5(2):211-213.

Zehir A, Nardi V, Konnick EQ, Lockwood CM, Long TA, Sidiropoulos N, et al. SPOT/Dx Pilot Reanalysis and College of American Pathologists Proficiency Testing for KRAS and NRAS Demonstrate Excellent Laboratory Performance. Arch Pathol Lab Med. 2024;148(2):139-148.

Omar M, Xu Z, Rand SB, Alexanderani MK, Salles DC, Valencia I, et al. Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images. Mol Cancer Res. 2024;22(4):347-359.

Min J, Zaslavsky A, Fedele G, McLaughlin SK, Reczek EE, De Raedt T, et al. Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB. Nat Med. 2024.

Chen C, Fahmy LM, Schreidah CM, Magro CM, Geskin LJ. Febrile Ulceronecrotic Mucha-Habermann Disease Associated With Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature. Am J Dermatopathol. 2024;46(4):238-242.

Jain D, Khandakar B, Ni P, Kenney B, Qin L, Deshpande V, et al. von Meyenburg complexes are more frequently associated with cholangiocarcinoma. J Clin Pathol. 2024.

Magro CM, Sanders S. Tumor necrosis factor ALPHA Inhibitor Associated Köhlmeier-Degos Disease as a Novel Iatrogenic Paradigm That Underscores Excessive Type I Interferon in Its Pathogenesis. Am J Dermatopathol. 2024;46(9):605-610.

Soderquist CR, Freeman C, Lin W-, Leeman-Neill RJ, Gu Y, Carter MC, et al. Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies. J Mol Diagn. 2024;26(1):5-16.